Another fundamental problem is these comparisons rely on U.S. medicines’ gross (or list) price. But list prices do not account for the complex U.S. drug supply chain, where manufacturers receive only a portion of the gross price and intermediaries,…
A federal program intended to help low-income patients has instead become a major revenue source for…
This week, the Senate Committee on Health, Education, Labor and Pensions will consider several bills…
If a charity organization collected billions of dollars with little evidence that needy people…
The Trump administration is ramping up its fight against waste, fraud, and abuse in healthcare. And…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.